Data / Drug companies / FlexiGo Inc
FlexiGo Inc: 13 products in the FDA NDC directory, labeler code 85524
FlexiGo Inc (labeler code 85524) lists 13 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 13 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85524
- Products in commercial distribution
- 13
- Packages
- 20
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 13
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 9
- Earliest marketing start
- September 20, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 8 | 61.5% |
| Generic drugs (ANDA) | 4 | 30.8% |
| New drug applications (NDA) | 1 | 7.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Minoxidil | 4 | 113 |
| Menthol | 4 | 263 |
| Glycerin 6%,lidocaine 4%,ectoin 0.12% | 1 | 1 |
| Lidocaine | 1 | 216 |
| Super vitamin c | 1 | 1 |
| Eyelash serum | 1 | 1 |
| Vitamin c | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 6 | 46.2% |
| Cream | 3 | 23.1% |
| Ointment | 1 | 7.7% |
| Paste | 1 | 7.7% |
| Patch | 1 | 7.7% |
| Aerosol, foam | 1 | 7.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Arteriolar Vasodilator | 4 |
| Amide Local Anesthetic | 2 |
| Antiarrhythmic | 2 |
| Vitamin C | 2 |
| Non-Standardized Chemical Allergen | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Minoxidil (for men) | 85524-2612 | Aerosol, foam | Generic drugs (ANDA) | November 2, 2026 |
| Minoxidil | 85524-2613 | Liquid | Generic drugs (ANDA) | October 21, 2026 |
| Minoxidil (for men) | 85524-2611 | Liquid | Generic drugs (ANDA) | June 8, 2026 |
| Hair Growth Serum Roll-ON | 85524-2625 | Liquid | Generic drugs (ANDA) | April 3, 2026 |
| Numbing | 85524-2605 | Cream | New drug applications (NDA) | March 28, 2026 |
| Vitamin C Serum | 85524-2627 | Liquid | Over the counter monograph drugs | January 31, 2026 |
| Hemorrhoid and Fissure | 85524-2602 | Ointment | Over the counter monograph drugs | January 19, 2026 |
| Pain Relieving Patch | 85524-2601 | Patch | Over the counter monograph drugs | January 18, 2026 |
| Eyelash Serum | 85524-2512 | Liquid | Over the counter monograph drugs | December 5, 2025 |
| Super vitamin C serum | 85524-2523 | Liquid | Over the counter monograph drugs | October 23, 2025 |
| Numbing Cream | 85524-2519 | Cream | Over the counter monograph drugs | October 17, 2025 |
| Numbing Cream | 85524-2520 | Cream | Over the counter monograph drugs | October 16, 2025 |
| Menthol | 85524-2510 | Paste | Over the counter monograph drugs | September 20, 2025 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.